Veracyte Inc (VCYT)
38.95
-0.25
(-0.64%)
USD |
NASDAQ |
Nov 21, 16:00
38.95
0.00 (0.00%)
After-Hours: 20:00
Veracyte Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.0011 |
| June 30, 2022 | 0.0011 |
| March 31, 2022 | 0.001 |
| December 31, 2021 | 0.001 |
| September 30, 2021 | 0.001 |
| June 30, 2021 | 0.0009 |
| March 31, 2021 | 0.0009 |
| December 31, 2020 | 0.0019 |
| September 30, 2020 | 0.0018 |
| June 30, 2020 | 0.0035 |
| March 31, 2020 | 0.0032 |
| December 31, 2019 | 0.0029 |
| September 30, 2019 | 0.0028 |
| June 30, 2019 | 0.0026 |
| March 31, 2019 | 0.1534 |
| December 31, 2018 | 0.317 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.3172 |
| June 30, 2018 | 0.9728 |
| March 31, 2018 | 0.8336 |
| December 31, 2017 | 0.6699 |
| September 30, 2017 | 0.5838 |
| June 30, 2017 | 0.5219 |
| March 31, 2017 | 0.4676 |
| December 31, 2016 | 0.4182 |
| September 30, 2016 | 0.8296 |
| June 30, 2016 | 0.7309 |
| March 31, 2016 | 0.5646 |
| December 31, 2015 | 0.0974 |
| September 30, 2015 | 0.0865 |
| June 30, 2015 | 0.0764 |
| March 31, 2015 | 0.1411 |
| December 31, 2014 | 0.119 |
| September 30, 2014 | 0.1037 |
| June 30, 2014 | 0.1104 |
| March 31, 2014 | 0.0981 |
| December 31, 2013 | 0.0868 |
| September 30, 2013 | 1.987 |
| June 30, 2013 | 0.5737 |
| March 31, 2013 | |
| December 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2022
0.0035
Maximum
Jun 2020
0.001
Average
0.0009
Median
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0005 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.4506 |
| Applied DNA Sciences Inc | 0.00 |
| OncoCyte Corp | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.275B |
| Total Liabilities (Quarterly) | 98.98M |
| Shareholders Equity (Quarterly) | 1.176B |
| Current Ratio | 5.075 |